Literature DB >> 22929411

Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.

Masaki Shimizu1, Mondo Kuroda, Natsumi Sakashita, Michio Konishi, Hisashi Kaneda, Noboru Igarashi, Junya Yamahana, Hiromichi Taneichi, Hirokazu Kanegane, Mika Ito, Shigeru Saito, Kazuhide Ohta, Takumi Taniguchi, Kengo Furuichi, Takashi Wada, Masaru Nakagawa, Hitoshi Yokoyama, Akihiro Yachie.   

Abstract

Proinflammatory cytokines are related to the pathogenesis of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic-uremic syndrome (HUS). We assessed the kinetics of the release of cytokines such as neopterin, interleukin (IL)-6, IL-8 and tumour necrosis factor (TNF)-α and the soluble forms of type I and II TNF receptors during EHEC O111-induced HUS (EHEC O111/HUS). Fourteen patients with EHEC O111/HUS were enrolled in this study. Serum concentrations of all cytokines other than TNF-α were significantly elevated in patients with severe HUS compared with those in patients with mild HUS. Although serum concentrations of TNF-α were not significantly higher in patients with severe HUS, most patients with acute encephalopathy showed elevated TNF-α levels. Serum concentrations of these cytokines rapidly and markedly increased, and massive hypercytokinaemia developed 1 day before the diagnosis of HUS in patients with severe HUS. Changes in the number of white blood cells and concentration of serum lactate dehydrogenase were significantly larger between the onset of hemorrhagic colitis and the time of the diagnosis of HUS in patients with severe HUS compared with those in patients with mild HUS. Proinflammatory cytokines play an important role in the pathogenesis of EHEC infection and development of severe complications, including HUS and encephalopathy. Monitoring the cytokine profile may be useful for assessing disease activity of EHEC O111 infections.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22929411     DOI: 10.1016/j.cyto.2012.07.038

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

Review 1.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

2.  Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.

Authors:  Masaki Shimizu; Natsumi Inoue; Mondo Kuroda; Hitoshi Irabu; Maiko Takakura; Hisashi Kaneda; Naotoshi Sugimoto; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2017-03-10       Impact factor: 2.801

3.  Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.

Authors:  Masaki Shimizu; Natsumi Inoue; Mondo Kuroda; Mao Mizuta; Naotoshi Sugimoto; Hisashi Kaneda; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2016-03-05       Impact factor: 2.801

4.  Characterization of enterohemorrhagic Escherichia coli O111 and O157 strains isolated from outbreak patients in Japan.

Authors:  Masanori Watahiki; Junko Isobe; Keiko Kimata; Tomoko Shima; Jun-ichi Kanatani; Miwako Shimizu; Akihiro Nagata; Keiko Kawakami; Mikiko Yamada; Hidemasa Izumiya; Sunao Iyoda; Tomoko Morita-Ishihara; Jiro Mitobe; Jun Terajima; Makoto Ohnishi; Tetsutaro Sata
Journal:  J Clin Microbiol       Date:  2014-05-14       Impact factor: 5.948

5.  Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice.

Authors:  Fumiko Obata; Priyanka B Subrahmanyam; Aimee E Vozenilek; Lauren M Hippler; Tynae Jeffers; Methinee Tongsuk; Irina Tiper; Progyaparamita Saha; Dakshina M Jandhyala; Glynis L Kolling; Olga Latinovic; Tonya J Webb
Journal:  Front Microbiol       Date:  2015-04-08       Impact factor: 5.640

6.  A hemolytic-uremic syndrome-associated strain O113:H21 Shiga toxin-producing Escherichia coli specifically expresses a transcriptional module containing dicA and is related to gene network dysregulation in Caco-2 cells.

Authors:  Silvia Yumi Bando; Priscila Iamashita; Beatriz E Guth; Luis F Dos Santos; André Fujita; Cecilia M Abe; Leandro R Ferreira; Carlos Alberto Moreira-Filho
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

7.  Species-specific enhancement of enterohemorrhagic E. coli pathogenesis mediated by microbiome metabolites.

Authors:  Alessio Tovaglieri; Alexandra Sontheimer-Phelps; Annelies Geirnaert; Rachelle Prantil-Baun; Diogo M Camacho; David B Chou; Sasan Jalili-Firoozinezhad; Tomás de Wouters; Magdalena Kasendra; Michael Super; Mark J Cartwright; Camilla A Richmond; David T Breault; Christophe Lacroix; Donald E Ingber
Journal:  Microbiome       Date:  2019-03-20       Impact factor: 14.650

8.  Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic Escherichia coli induced hemolytic uremic syndrome.

Authors:  Yuko Tasaki; Natsumi Inoue; Masaki Shimizu; Naotoshi Sugimoto; Sayaka Ishikawa; Mao Mizuta; Tadafumi Yokoyama; Mondo Kuroda; Kazuhide Ohta; Akihiro Yachie; Taizo Wada
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

9.  STEC:O111-HUS complicated by acute encephalopathy in a young girl was successfully treated with a set of hemodiafiltration, steroid pulse, and soluble thrombomodulin under plasma exchange.

Authors:  Noritaka Yada; Masayuki Fujioka; Charles L Bennett; Kazuya Inoki; Toyokazu Miki; Akihiko Watanabe; Toshiko Yoshida; Masaki Hayakawa; Masanori Matsumoto; Yoshihiro Fujimura
Journal:  Clin Case Rep       Date:  2015-02-02

10.  Environmental Cues Modulate Microglial Cell Behavior Upon Shiga Toxin 2 From Enterohemorrhagic Escherichia coli Exposure.

Authors:  Clara Berdasco; Maite Duhalde Vega; María Victoria Rosato-Siri; Jorge Goldstein
Journal:  Front Cell Infect Microbiol       Date:  2020-01-08       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.